| Financial Year |
March 31 2023 |
| Monetary Funds |
1,043,911,172.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,650,000.23 |
| Accounts Receivable |
46,607,305.17 |
| Advances to Suppliers |
10,847,713.20 |
| Other Receivables |
9,171,593.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,312,484.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,127,068.04 |
| Total Current Assets |
1,335,435,966.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
167,600.24 |
| Fixed Assetes |
312,243,211.44 |
| Under-construction Projects |
362,654.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,880,245.45 |
| R&D expenses |
-- |
| Goodwill |
517,835.51 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,363,932.37 |
| Other Non-Current Assets |
9,944,038.23 |
| Sub-Total of Non-Current Assets |
355,832,353.91 |
| Total Assets |
1,691,268,320.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
94,966,301.36 |
| Accounts Received In Advance |
469,341.05 |
| Employee Compensation Payable |
12,171,704.27 |
| Taxes Payable |
6,018,447.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,320,533.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
634,984.85 |
| Other Current Liabilities |
15,762,438.36 |
| Sub-Total of Current Liabilities |
202,623,633.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,812,303.69 |
| Total Liabilities |
224,435,937.28 |
| Paid-In Capital(Or Share Stock) |
64,000,000.00 |
| Capital Surplus |
654,948,556.43 |
| Surplus Reserve |
88,816,035.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
659,067,791.74 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,466,832,383.57 |
| Owner's Equity（Stockholder's Equity） |
1,466,832,383.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,691,268,320.85 |
